IFPMA Covid-19 Günlük Bülteni – 7 Mayıs

07.05.2020

Top news:

  • The UN Office for the Coordination of Humanitarian Affairs launched the updated COVID-19 Global Humanitarian Response Plan with financing requirements over a period of nine months (April-December 2020) are estimated to be US$2.012 billion.
  • The EU is to put forward proposals for a mechanism to learn from the COVID-19 pandemic at the next meeting of the WHO.
  • EU Parliament’s Committee on International Trade shares draft opinion on shortage of medicines; urging the Commission and the Member States to work with the WHO and WTO, on establishing an international framework that can prevent the breakdown of supply chains and limit resort to protectionist measures during health crises.
  • Latest version of the EU draft COVID-19 resolution includes a proposal to investigate the source of the virus and how it was introduced to the human population, effectively involving China.
  • During a WHO AFRO media briefing, Dr Matshidiso Moeti, WHO Regional Director for Africa, expressed concerns about the impact of COVID-19 on the ability of African countries to progress towards UHC & COVID-19 likely to peak in four to six weeks if nothing is done.
  • Pfizer tags 3 U.S. and Belgian manufacturing sites for possible COVID-19 vaccine launch.

WORLD HEALTH ASSEMBLY

  • Politico Pro: WHO Assembly to meet virtually over two days to address pandemic response. The adoption of the assembly’s COVID-19 response is the only substantive item on the provisional agenda for the 73rd WHA. The EU-sponsored resolution is largely in line with an earlier draft. However, this latest version includes a proposal to investigate the source of the virus and how it was introduced to the human population, effectively involving China. The idea has been championed by EU Commission President Ursula von der Leyen, who has publicly stated her support for an investigation. EU resolution draft as of May 6here.

GLOBAL RESPONSE

ACCESS, PRICING & IP

  • GreenWorld: A patented Covid-19 vaccine could price out millions. The Costa Rica proposal is “not effective and not necessary”, Richard Wilder, general legal counsel of CEPI. Wilder argues that pharmaceutical companies, biotech firms and academic labs will refuse to share their vaccine technologies and scientific processes and there is “simply no time now” to do anything different than usual. This then becomes a key question of the hour: is the need for a Covid-19 vaccine, its manufacture and its distribution now so great that “business as usual”, as Ellen ‘t Hoen puts it, is a non-starter? And will governments require patent holders to share?
  • Reuters: Will Gilead price its coronavirus drug for public good or company profit?  The article states Gilead faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.

SUPPLY CHAIN

Europe

  • European Parliament: Draft opinion on shortage of medicines – how to address an emerging problem. The Committee on International Trade published an opinion on the shortage of medicines. Generally it strikes a balanced tone between the need to ensure security of supply and understanding the fact that supply chains will inevitably be global.
    • On the impact of COVID on medicines supply chains it notes “the vital role played by functioning global supply chains for medical products, and in particular for medicines; emphasises that an open, rules-based trading system is fundamental to ensuring the global availability of medicines”.
    • It further emphasises that the EU is a leading global exporter of pharmaceutical products; and notes that the protection and enforcement of IP rights in free trade agreements (FTAs) and at the WTO is crucial to the development of new medicines and treatments.
    • Furthermore, it calls on the Commission to present a long-term strategy focused on ensuring the EU’s open strategic autonomy in health and urges the Commission and the Member States to work with the EU’s partners, the WHO and WTO, on establishing an international framework that can prevent the breakdown of supply chains and limit resort to protectionist measures during health crises.

United States

MANUFACTURING

VACCINE/ TREATMENT DEVELOPMENT

IFPMA members

Others

DIAGNOSTICS

DISEASE SOUCRE & CHARACTERISTICS

COVID-19 & EARNINGS

WHO – COVID-19 UPDATE, 7 May

No media briefing by Dr Tedros today.

WHO AFRO COVID-19 joint media briefing with WEF – by Dr Matshidiso Moeti, WHO Regional Director for Africa

  • She said there are now around 50,000 confirmed cases and 2000 have lost their lives across the African continent.
  • She highlighted the importance of countries using data-driven, evidence-based approaches in the response.
  • WHO AFRO is working together with countries to leverage assets in place for preparedness for Ebola, HIV, TB and polio and scale-up coordination, mobilizing people and repair global and local supply chains.
  • She voiced her concern about the impact that COVID-19 will have on the ability of African countries to progress towards UHC.
  • She stated she is convinced that the tests that have been provided and that are on the national market and those that were provided by the WHO and the Jack Ma Foundation are not contaminated with the virus.
  • She said that they are estimating that COVID-19 will peak in four to six weeks if nothing is done.

WHO EURO COVID-19 media briefing – by Hans Kluge, WHO Regional Director for Europe

  • WHO has sent an expert mission on the ground in Tajikistan who are working with national authorities and health providers to respond to the outbreak in the country. It is the latest of over 60 missions we have conducted across the European Region during this pandemic.
  • WHO is deeply troubled by the reports from many countries, including Belgium, Bulgaria, France, Ireland, Russian Federation, Spain, UK, and others of increases in interpersonal violence including violence against women and men, by an intimate partner and against children – because of the COVID-19 response.
  • UNFPA has sounded the alarm loud and clear – if lockdowns were to continue for 6 months, we would expect an extra 31 million cases of gender-based violence globally.
  • In the coming days, WHO will be releasing an overview of key actions now and in the future to prevent and respond to this surge in violence against children, women and older people.